EDIT-301 was well-tolerated and demonstrated a safety profile consistent with myeloablative conditioning with busulfan and autologous hematopoietic stem cell transplant Both patients treated with EDIT ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback